Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Aug 3, 2021, before the open
10-Q filed Aug 3, 2021, 34 days after period end · 0001558370-21-009963
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $274.00K | — | — | — |
| Net Income | -$35.39M | -$31.12M | -$42.80M | -$14.41M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| -$0.70 |
| -$0.71 |
| -$1.24 |
| -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.